Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released May 7, 2026, before the open
10-Q filed May 7, 2026, 37 days after period end · 0001104659-26-057110
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $106.51M | $41.14M | $74.88M | $104.06M |
| Net Income | $40.77M | -$37.39M | -$4.16M | $45.71M |
| EPS Diluted |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| $0.24 |
| -$0.23 |
| -$0.03 |
| $0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.